Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Patient-Centered Adherence Intervention After ACS Hospitalization
Brief Summary: We propose to test the effectiveness of a multi-faceted patient-centered adherence intervention among veterans following ACS hospitalization to improve adherence to cardioprotective medications (primary aim). Secondary aims will assess whether the intervention improves achievement of secondary prevention blood pressure (BP) and low density lipoprotein (LDL)-cholesterol goals, reduces cardiac endpoints (myocardial infarction ) MI hospitalization, coronary revascularization, all-cause mortality) and is cost-effective.

ANTICIPATED IMPACT(S) : If successful, the proposed intervention will increase adherence to cardioprotective medications (i.e., -blockers, statins, clopidogrel, and ACE inhibitors) by helping veterans take their medications routinely as prescribed, the quality of cardiovascular care for veterans by helping patients achieve BP and LDL goals which have been associated with improved outcomes, and the efficiency of care by using telephone calls and tele-monitoring for communication with patients rather than clinic visits. The findings of the study will address an important gap in knowledge (i.e., how to improve adherence to medications following ACS discharge) and will be generalizable to other VA Medical Centers and veterans.


Options:
A: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Other: High Intensity Intervention, Other: All- 6 month pharmacist intervention | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Low Intensity Intervention, Other: All- 6 month pharmacist intervention | Intervention Type: OTHER; Name: High Intensity Intervention; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: Low Intensity Intervention; Assigned to Arm(s): Arm 2 | Intervention Type: OTHER; Name: All- 6 month pharmacist intervention; Assigned to Arm(s): Arm 1, Arm 2
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Monitoring by an HIV-trained medical doctor, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Monitoring by an HIV-trained primary care nurse, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine | Intervention Type: BEHAVIORAL; Name: Monitoring by an HIV-trained medical doctor; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Monitoring by an HIV-trained primary care nurse; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): A, B
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Arm 2
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: Other: Case Management | Arm Label: Case Management; Type: EXPERIMENTAL; Interventions: Other: Case Management | Intervention Type: OTHER; Name: Case Management; Assigned to Arm(s): Case Management, Usual Care

Answer: C